Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Final Astroworld suit settled
At least 100 killed in landslide
'This means war'
'Doge' meme dog dies
US issues visa restrictions
2 shot at graduation event
Duggan can be extradited
Signs new abortion bill
2022 Osprey crash lawsuit
Wash. wind farm proposal
First teaser revealed
Arrested, charged w/ fraud
Planet parade 2024
Support AIDS research
Approves ETFs for Ether
Bong's plane discovered?
Lovett joins ‘Survivor’ cast
Gets Walk of Fame star
Planet that could support life
US service members injured
Priest bites woman?
Daytime Emmy Awards hosts
Wins Idaho caucuses
Judge revisits immigration law
Drops ‘Dark Times' album
Ala. coal ash plan rejected
To hold output policy meeting
OH gov. calls special session
China's 2nd day of war games
CIA director to visit Europe
AI deals with Hollywood?
Official images of B21 Raider
Pistons new president?
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Sanofi
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi (SNY, FR:SAN). Novavax sha
Novavax's share price surges after inking co-licensing deal with pharma giant
Gaithersburg's Novavax is getting a big cash infusion after signing a multibillion-dollar deal with French pharmaceutical giant. It's also removing a going-concern warning it issued more than a year ago.
Benefits Pro
11d
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
With flu and COVID hospital admission rates now mirroring each other,
Novavax
, which lost out in the COVID
vaccine
race ...
4d
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback